loading
Oric Pharmaceuticals Inc stock is traded at $13.10, with a volume of 1.46M. It is up +5.48% in the last 24 hours and up +25.24% over the past month. ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
See More
Previous Close:
$12.42
Open:
$12.58
24h Volume:
1.46M
Relative Volume:
1.09
Market Cap:
$1.27B
Revenue:
-
Net Income/Loss:
$-137.25M
P/E Ratio:
-6.9312
EPS:
-1.89
Net Cash Flow:
$-121.97M
1W Performance:
+2.50%
1M Performance:
+25.24%
6M Performance:
+152.41%
1Y Performance:
+55.21%
1-Day Range:
Value
$12.47
$13.38
1-Week Range:
Value
$11.71
$13.38
52-Week Range:
Value
$3.8951
$14.93

Oric Pharmaceuticals Inc Stock (ORIC) Company Profile

Name
Name
Oric Pharmaceuticals Inc
Name
Phone
(650) 388-5600
Name
Address
240 E. GRAND AVE., SOUTH SAN FRANCISCO, CA
Name
Employee
128
Name
Twitter
Name
Next Earnings Date
2024-11-04
Name
Latest SEC Filings
Name
ORIC's Discussions on Twitter

Compare ORIC with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ORIC
Oric Pharmaceuticals Inc
13.10 1.21B 0 -137.25M -121.97M -1.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
421.39 108.36B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
463.43 60.82B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
577.95 61.02B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
817.32 50.01B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
310.81 34.05B 4.56B -176.77M 225.30M -1.7177

Oric Pharmaceuticals Inc Stock (ORIC) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-04-25 Resumed Guggenheim Buy
Jul-08-25 Initiated Ladenburg Thalmann Buy
Oct-31-24 Initiated Wells Fargo Overweight
Sep-06-24 Initiated Stifel Buy
Feb-23-24 Initiated Cantor Fitzgerald Overweight
Sep-22-23 Initiated Wedbush Outperform
Mar-23-23 Upgrade H.C. Wainwright Neutral → Buy
Mar-21-23 Upgrade Guggenheim Neutral → Buy
Mar-16-23 Upgrade Oppenheimer Perform → Outperform
Jul-18-22 Resumed Oppenheimer Perform
Apr-04-22 Upgrade Citigroup Neutral → Buy
Mar-25-22 Downgrade H.C. Wainwright Buy → Neutral
Mar-22-22 Downgrade Citigroup Buy → Neutral
Mar-22-22 Downgrade Guggenheim Buy → Neutral
Mar-22-22 Downgrade Oppenheimer Outperform → Perform
Jul-06-21 Upgrade Citigroup Neutral → Buy
Jan-25-21 Downgrade Citigroup Buy → Neutral
Aug-13-20 Initiated Robert W. Baird Outperform
Aug-06-20 Upgrade Citigroup Neutral → Buy
Aug-03-20 Initiated H.C. Wainwright Buy
May-19-20 Initiated Citigroup Neutral
May-19-20 Initiated Guggenheim Buy
May-19-20 Initiated JP Morgan Overweight
May-19-20 Initiated Jefferies Buy
View All

Oric Pharmaceuticals Inc Stock (ORIC) Latest News

pulisher
Oct 25, 2025

What technical models suggest about ORIC Pharmaceuticals Inc.’s comebackJuly 2025 Sector Moves & Weekly Market Pulse Updates - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Why ORIC Pharmaceuticals Inc. (4TZ) stock stays on top picksTrade Analysis Summary & Weekly Top Performers Watchlists - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Has ORIC Pharmaceuticals Inc. found a price floorJuly 2025 Setups & Technical Confirmation Trade Alerts - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Will ORIC Pharmaceuticals Inc. stock split again soonEarnings Risk Summary & Detailed Earnings Play Alerts - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Relative strength of ORIC Pharmaceuticals Inc. in sector analysisWeekly Gains Summary & AI Forecast for Swing Trade Picks - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Sentiment analysis tools applied to ORIC Pharmaceuticals Inc.July 2025 Retail & Risk Controlled Stock Pick Alerts - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

How to read the order book for ORIC Pharmaceuticals Inc.July 2025 Review & Real-Time Chart Breakout Alerts - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Can you recover from losses in ORIC Pharmaceuticals Inc.2025 Breakouts & Breakdowns & Community Shared Stock Ideas - newser.com

Oct 25, 2025
pulisher
Oct 24, 2025

Oric Pharmaceuticals, Inc. (ORIC) Investor Outlook: A Promising 47% Upside Potential Amid Innovative Cancer Therapies - DirectorsTalk Interviews

Oct 24, 2025
pulisher
Oct 23, 2025

BDTX vs. ORIC: Which Oncology Focused Biotech Stock Is a Better Pick Now? - sharewise.com

Oct 23, 2025
pulisher
Oct 22, 2025

TD Asset Management Inc Raises Position in Oric Pharmaceuticals, Inc. $ORIC - MarketBeat

Oct 22, 2025
pulisher
Oct 21, 2025

Historical volatility pattern of ORIC Pharmaceuticals Inc. visualizedWeekly Profit Report & Verified Technical Trade Signals - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Candlestick signals on ORIC Pharmaceuticals Inc. stock todayEarnings Summary Report & Capital Efficient Trading Techniques - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Analyzing drawdowns of ORIC Pharmaceuticals Inc. with statistical tools2025 Winners & Losers & Weekly Consistent Profit Watchlists - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

Published on: 2025-10-20 19:38:47 - newser.com

Oct 20, 2025

Oric Pharmaceuticals Inc Stock (ORIC) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.26
price up icon 1.11%
$91.28
price up icon 2.21%
$29.89
price up icon 0.07%
$105.66
price up icon 0.87%
$159.66
price down icon 0.29%
biotechnology ONC
$310.81
price up icon 0.25%
Cap:     |  Volume (24h):